Supply resiliency during unprecedented times

The Coronavirus pandemic reveals how vulnerable the drug supply chain can be. In this episode, we will discuss what frontline pharmacists need to know to ensure essential medications are available and the drug supply remains resilient.

 

Guest speakers:

Doug Kucera

Associate Vice President

Contract Services, Pharmacy

Vizient

 

Mittal Sutaria, PharmD

Vice President

Contract and Program Services, Pharmacy

Vizient

 

Moderator:

Gretchen Brummel, PharmD, BCPS

Pharmacy Executive Director

Vizient Center for Pharmacy Practice Excellence

 

Show Notes:

[01:21] Demand for Propofol for COVID ventilated patients skyrocketed to 272%

[01:46] Private label programs provides resiliency to the market

[02:31] How to strengthen pharmacy supply chain

[03:45] Drug shortage task force objectives

[05:51] Essential Medication Lists

[06:47] Labor cost for managing drug shortages

[08:03] Prioritize Essential Medication List and educate others   

[08:26] Elevate the transparency, accountability and resiliency of the pharmaceutical supply chain  

[09:59] Frontline pharmacist advocacy plays a huge role

[10:36] Ask questions to make sure the solution is in the best interest for your pharmacy

 

Links | Resources:

Vizient’s Novaplus Enhanced Supply Program Enabled Access to 676,000 Additional Units of propofol as COVID-19 Cases Surged, Click here

Essential Medications for Patient Care, Click here

Drug shortages and labor costs: Measuring a hidden cost of drug shortages on U.S. hospitals, Click here

Essential medications review (November 2020), Click here

Vizient Identifies Essential Medications in Hospitals and Highlights Fragility of the Supply Chain, Click here

 

Subscribe Today!

Apple Podcasts

Spotify

Google Podcasts

Stitcher

Android

RSS Feed

 

Share | Download(Loading)

Episodes Date

Load more